Aclarion, Inc.
NASDAQFour ACON insiders purchased shares in the days leading into tomorrow's earnings — a cluster of buying that stands out against one of the most heavily shorted float profiles in the small-cap health tech space. The buying started May 6, when a director picked up 1,562 shares at $3.30. CEO Brent Ness followed on May 11, adding 6,289 shares at $3.18 for roughly $20,000. A second…
ACON short interest jumps 28% in one week to 35.9% of float, marking a sharp accumulation by bearish traders despite stock decline.
Snapshot as of 23 Jun 2026
Four ACON insiders purchased shares in the days leading into tomorrow's earnings — a cluster of buying that stands out against one of the most heavily shorted float profiles in the small-cap health tech space. The…
ACON heads into its Q1 results — just reported after the close on May 13 — with a striking contrast: management buying stock with both hands while short sellers have been aggressively rebuilding positions over the past…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ACON — free to start on ORTEX.
Sign up for free →Open ACON on ORTEX